Refining organs at risk protection in head and neck radiotherapy: Volumetric Modulated Arc Therapy efficacy in cochlea and adjacent structures sparing
Rawal Medical Journal · 2026
DOI: 10.5455/rmj.20260128072448 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rawal Medical Journal, 2026. Die Arbeit nennt 57 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate the dosimetric effectiveness of Volumetric Modulated Arc Therapy (VMAT) in head and neck cancer (HNC) patients, specifically focusing on optimizing tumor coverage while sparing critical organs at risk (OAR), such as the cochlea, to minimize functional toxicity. Methodology: This retrospective study analyzed VMAT plans for nine male HNC patients (aged 50–60). Treatment plans were generated using the Monaco system with the Monte Carlo algorithm. Target coverage and OAR dose constraints (cochlea, optic chiasm, and larynx) were evaluated using dose-volume histograms.
Results
VMAT demonstrated high-quality planning, achieving excellent target coverage (98.79%±1.13). Doses to critical structures remained within clinical tolerances: mean cochlear dose
Zitieren
APA
(2026). Refining organs at risk protection in head and neck radiotherapy: Volumetric Modulated Arc Therapy efficacy in cochlea and adjacent structures sparing. Rawal Medical Journal. https://doi.org/10.5455/rmj.20260128072448
Vancouver
Refining organs at risk protection in head and neck radiotherapy: Volumetric Modulated Arc Therapy efficacy in cochlea and adjacent structures sparing. Rawal Medical Journal. 2026. doi:10.5455/rmj.20260128072448
BibTeX
@article{euvimed2026,
title = {Refining organs at risk protection in head and neck radiotherapy: Volumetric Modulated Arc Therapy efficacy in cochlea and adjacent structures sparing},
journal = {Rawal Medical Journal},
year = {2026},
doi = {10.5455/rmj.20260128072448}
}
EUVIMED